The company will still have some catching up to do, as LM-299 is early in clinical development, with a phase 1 trial ...
On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...
Shipping giant CMA CGM has asked its customers to be ready with the additional mandatory data required to be provided under the European Unions’ Import Control System 2 (ICS2) regulations, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback